Stanford University — Cancer Translational Nanotechnology Training Program

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Stanford University

Principal Investigator: Jianghong Rao, Ph.D., and Dean Felsher, M.D., Ph.D.

Training Focus and Objectives

The Stanford Cancer-Translational Nanotechnology Training (Cancer-TNT) Program is a diverse and synergistic 3-year training program bringing together 25 faculty in 9 departments from three schools to train the next generation of interdisciplinary leaders who will pursue challenges in cancer research and clinical translation. During the proposed 5-year cycle, we will recruit a total of 12 postdoctoral trainees to provide them with education and cross-disciplinary training to develop interdisciplinary researchers in cancer nanotechnology translation. Our trainees' skill sets will bridge multiple disciplines such as chemistry, molecular biology, bioengineering, nanoengineering, molecular imaging, and clinical cancer medicine. Trainees will be able to advance cancer research, diagnosis, and management. The 3-year program includes coursework and research with two complementary mentors. The course work will be selected in cancer biology, cancer immunology, molecular imaging, molecular pharmacology, and gene therapy, nanomedicine, micro/nanofabrication, biochips, electrical engineering, and materials science, in consultation with the program director and research advisor. In addition, hands-on training activities in Nanocharacterization and a clinical component including Stanford Oncology Clinical Lecture Series will be offered. In their second year trainees will prepare a mock grant proposal to help them gain experience and confidence in the grant application process. A Training Committee will oversee trainee progress, with an Advisory Committee monitoring the entire program.

Visit the Stanford CNTC website.

  • Posted: August 8, 2017

Most text on the National Cancer Institute website may be reproduced or reused freely. The National Cancer Institute should be credited as the source. Please note that blog posts that are written by individuals from outside the government may be owned by the writer, and graphics may be owned by their creator. In such cases, it is necessary to contact the writer, artist, or publisher to obtain permission for reuse.

We welcome your comments on this post. All comments must follow our comment policy.